Healthcare & Pharma
Companies in Sector
15
Total Sector Debt
$289.5B
High Risk
0
Avg Risk Score
2.9
| Company | Risk Score | Total Debt | 12mo Due |
|---|---|---|---|
|
AbbVie Inc.
ABBV |
5/10 Medium Risk | $64.5B | $6.0B |
|
AMGEN INC
AMGN |
5/10 Medium Risk | $60.1B | $4.6B |
|
PFIZER INC
PFE |
5/10 Medium Risk | $4.0B | N/A |
|
BRISTOL MYERS SQUIBB CO
BMY |
4/10 Medium Risk | $49.4B | $2.0B |
|
GILEAD SCIENCES, INC.
GILD |
4/10 Medium Risk | $26.7B | $2.8B |
|
UNITEDHEALTH GROUP INC
UNH |
4/10 Medium Risk | N/A | $6.1B |
|
ELI LILLY & Co
LLY |
3/10 Low Risk | $19.1B | $781M |
|
Merck & Co., Inc.
MRK |
3/10 Low Risk | N/A | $2.6B |
|
BIOGEN INC.
BIIB |
2/10 Low Risk | $6.3B | $0 |
|
Cigna Group
CI |
2/10 Low Risk | N/A | $550M |
|
CVS HEALTH Corp
CVS |
2/10 Low Risk | $27.0B | $4.0B |
|
Zoetis Inc.
ZTS |
2/10 Low Risk | N/A | $0 |
|
JOHNSON & JOHNSON
JNJ |
1/10 Low Risk | $32.4B | $2.0B |
|
REGENERON PHARMACEUTICALS, INC.
REGN |
1/10 Low Risk | N/A | N/A |
|
VERTEX PHARMACEUTICALS INC / MA
VRTX |
1/10 Low Risk | N/A | N/A |